Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Shanghai Renhui Biopharmaceutical.

    Client Virtual Booth

    SHANGHAI RENHUI BIOPHARMACEUTICAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Shanghai Renhui Biopharmaceutical
    China Flag
    Country
    Country
    China
    Address
    Address
    No. 916, Ziping Road, Zhoupu, Pudong New Area, Shanghai
    Telephone
    Telephone
    +86-21-61905511
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.benemae.com/welcome.html
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Renhui Bio Announced that the Application for the Marketing of Benaglutide Injection for Weight Loss Indications has been Accepted in China

    Details:

    Yishengtai (benaglutide) is a fully human GLP-1 drug, which mainly used for weight loss effect in the clinical use of type 2 diabetes and comprehensive benefits for overweight and mechanisms such as enhancing satiety, delaying gastric emptying.


    Lead Product(s): Beinaglutide

    Therapeutic Area: Endocrinology Product Name: Yishengtai

    Highest Development Status: ApprovedProduct Type: Peptide

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable March 15, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    The Clinical Application for the New Pump Administration Method of Benaglutide for Weight Loss Indications was Approved

    Details:

    Yishengtai (benaglutide) is a fully human GLP-1 drug, which mainly used for weight loss effect in the clinical use of type 2 diabetes and comprehensive benefits for overweight and mechanisms such as enhancing satiety, delaying gastric emptying.


    Lead Product(s): Beinaglutide

    Therapeutic Area: Endocrinology Product Name: Yishengtai

    Highest Development Status: ApprovedProduct Type: Peptide

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 08, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search